Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease
Advanced Science · 2025-10 · 12 (37)
DOI: 10.1002/advs.202505168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.07.2025. Verfasst von Zerun Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Ferroptosis, Antioxidants, Diabetic Nephropathies, Kidney Tubules. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province, Key Research Project of Ningxia Hui Autonomous Region of China.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) imposes a heavy medical burden worldwide due to the lack of effective treatment. High levels of mtROS and mitochondrial damage in the renal tubules are the initiating and core factors driving the progression of DKD. However, the effectiveness of current antioxidant drugs is greatly limited, mainly due to the difficulty of simultaneously breaching the glomerular barrier and targeting tubular mitochondria, as well as their limited ability to sustain treatment of chronic DKD. Here, this study reports a Se embedded adaptive antioxidant nanodrug (AAN) with negative surface charge and high mitochondrial targeting that can pass through the renal tubules and be highly enriched in the affected renal tubular mitochondria in DKD. AAN can eliminate mtROS to release soluble Se, which is then converted into the key bioactive enzymes ‐GPX4, effectively inhibiting ferroptosis and protecting mitochondria by exerting adaptive antioxidant effects. In the DKD mouse model, AAN treatment can effectively restore renal function, and the therapeutic effect at a dose of 10 mg kg −1 every 4 days is significantly better than Metformin administered at a dose of 200 mg kg −1 per day. In conclusion, this study provides a promising strategy to enhance the effects of antioxidant therapy to break the pathological barriers in DKD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, China.
- Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
- Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
ORCID-Profile: Kelong Ai
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Hunan Province
- Key Research Project of Ningxia Hui Autonomous Region of China
- Central South University Research Program of Advanced Interdisciplinary Studies
- Project Program of National Clinical Research Center for Geriatric Disorders
- Fundamental Research Funds for the Central Universities of Central South University
Zitieren
APA
Liu, Z., Huang, T., Hong, Y., Yang, Y., Chen, W., Zeng, Q., Chen, Q., Yang, Y., Ying, X., Zeng, W., Wu, Z., Zhao, T., Wan, X., Chen, J., Ai, K., & Huang, Q. (2025). Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease. Advanced Science, 12(37). https://doi.org/10.1002/advs.202505168
Vancouver
Liu Z, Huang T, Hong Y, Yang Y, Chen W, Zeng Q, et al. Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease. Advanced Science. 2025;12(37). doi:10.1002/advs.202505168
BibTeX
@article{Liu2025,
author = {Liu, Zerun and Huang, Ting and Hong, Ying and Yang, Yuqi and Chen, Wensheng and Zeng, Qingtao and Chen, Qiaohui and Yang, Yongqi and Ying, Xiaohong and Zeng, Wan and Wu, Ziyu and Zhao, Tianjiao and Wan, Xuesi and Chen, Jianlin and Ai, Kelong and Huang, Qiong},
title = {Adaptive Antioxidant Nanomedicines Inhibit Ferroptosis in Renal Tubular Epithelial Cells to Alleviate Diabetic Kidney Disease},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {37},
doi = {10.1002/advs.202505168}
}
EUVIMED